The retinamide VNLG ‐152 inhibits AR/AR‐V7 and MNK‐eIF4Esignaling pathways to suppress EMT and castration‐resistant prostate cancer xenograft growth

This article is protected by copyright. All rights reserved.

Source: FEBS Journal - January 11, 2018 Category: Research Authors: Vidya P. Ramamurthy, Senthilmurugan Ramalingam, Lalji K. Gediya, Vincent C.O. Njar Tags: Original Article Source Type: research